Criterion Capital Advisors LLC Sells 213 Shares of Corteva, Inc. (NYSE:CTVA)

Criterion Capital Advisors LLC reduced its stake in Corteva, Inc. (NYSE:CTVA) by 31.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 463 shares of the company’s stock after selling 213 shares during the period. Criterion Capital Advisors LLC’s holdings in Corteva were worth $27,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Rise Advisors LLC lifted its position in shares of Corteva by 2,522.2% in the 1st quarter. Rise Advisors LLC now owns 472 shares of the company’s stock worth $27,000 after purchasing an additional 454 shares during the period. CVA Family Office LLC purchased a new stake in shares of Corteva in the 4th quarter worth approximately $25,000. Ironwood Wealth Management Inc. lifted its position in shares of Corteva by 106.1% in the 1st quarter. Ironwood Wealth Management Inc. now owns 544 shares of the company’s stock worth $31,000 after purchasing an additional 280 shares during the period. Scarborough Advisors LLC purchased a new stake in shares of Corteva in the 4th quarter worth approximately $29,000. Finally, BKM Wealth Management LLC purchased a new stake in shares of Corteva in the 4th quarter worth approximately $27,000. 81.54% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CTVA has been the subject of several research reports. Royal Bank of Canada upped their price target on shares of Corteva from $62.00 to $64.00 and gave the stock an “outperform” rating in a research report on Monday, May 6th. Canaccord Genuity Group increased their target price on shares of Corteva from $60.00 to $65.00 and gave the company a “buy” rating in a research report on Friday, May 3rd. Mizuho decreased their target price on shares of Corteva from $61.00 to $60.00 and set a “buy” rating for the company in a research report on Tuesday, June 18th. KeyCorp increased their target price on shares of Corteva from $63.00 to $66.00 and gave the company an “overweight” rating in a research report on Tuesday, April 9th. Finally, BMO Capital Markets increased their target price on shares of Corteva from $64.00 to $67.00 and gave the company an “outperform” rating in a research report on Friday, May 3rd. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $63.00.

Insider Buying and Selling

In related news, SVP Cornel B. Fuerer sold 39,736 shares of the business’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $57.41, for a total transaction of $2,281,243.76. Following the transaction, the senior vice president now directly owns 126,628 shares in the company, valued at $7,269,713.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Samuel R. Eathington sold 31,686 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $57.64, for a total value of $1,826,381.04. Following the sale, the insider now directly owns 53,854 shares of the company’s stock, valued at approximately $3,104,144.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Cornel B. Fuerer sold 39,736 shares of the business’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $57.41, for a total transaction of $2,281,243.76. Following the completion of the sale, the senior vice president now directly owns 126,628 shares in the company, valued at $7,269,713.48. The disclosure for this sale can be found here. Over the last three months, insiders have sold 83,556 shares of company stock worth $4,795,016. 0.14% of the stock is owned by insiders.

Corteva Stock Performance

CTVA traded up $0.29 on Friday, reaching $53.94. The stock had a trading volume of 6,301,369 shares, compared to its average volume of 3,420,539. Corteva, Inc. has a 12-month low of $43.22 and a 12-month high of $58.76. The company has a current ratio of 1.51, a quick ratio of 0.97 and a debt-to-equity ratio of 0.10. The business’s 50-day moving average price is $54.77 and its two-hundred day moving average price is $52.73. The company has a market cap of $37.60 billion, a P/E ratio of 68.28, a price-to-earnings-growth ratio of 1.43 and a beta of 0.78.

Corteva (NYSE:CTVA) last announced its earnings results on Wednesday, May 1st. The company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.10. Corteva had a net margin of 3.32% and a return on equity of 6.68%. The business had revenue of $4.49 billion for the quarter, compared to analyst estimates of $4.65 billion. During the same quarter last year, the business earned $1.16 earnings per share. The company’s revenue for the quarter was down 8.0% compared to the same quarter last year. Sell-side analysts forecast that Corteva, Inc. will post 2.8 earnings per share for the current year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 18th. Stockholders of record on Tuesday, June 4th were given a $0.16 dividend. The ex-dividend date was Tuesday, June 4th. This represents a $0.64 annualized dividend and a dividend yield of 1.19%. Corteva’s dividend payout ratio (DPR) is 81.01%.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.